HEMOPHILIA A CARRIER DETECTION Test
At DNA Labs UAE, we offer the HEMOPHILIA A CARRIER DETECTION Test to determine if an individual carries the gene mutation for hemophilia A. Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII.
Test Cost: AED 2450.0
Symptoms and Diagnosis
Carriers of the gene mutation for hemophilia A do not typically show symptoms of the disorder but can pass the gene mutation onto their children. The HEMOPHILIA A CARRIER DETECTION Test involves analyzing a blood sample to detect the presence of the gene mutation responsible for hemophilia A.
Test Components
- Factor VIII
- vWF Antigen
- Factor VIII / vWF Ratio
Sample Condition
3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally transfer the supernatant (PPP) to 1 labelled, clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory.
Report Delivery
Sample 1st & 3rd Mon by 11 am; Report Next day
Method
Electromechanical Clot Detection, EIA
Test Type
Disorders of Coagulation
Doctor
Hematologist
Test Department
Pre Test Information
Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15) is mandatory. It is recommended that the patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with the prior consent of the treating Physician.
Test Details
The Hemophilia A carrier detection test is a genetic test used to determine if an individual carries the gene mutation for hemophilia A. This test is usually performed on women who have a family history of hemophilia A or who are at risk of being carriers. The test involves analyzing a blood sample to detect the presence of the gene mutation responsible for hemophilia A.
If a woman is found to be a carrier, there is a 50% chance that she will pass the gene mutation onto her children. This information can help individuals make informed decisions about their reproductive options and medical management.
It is important to note that this test specifically detects the gene mutation for hemophilia A and not other types of hemophilia or bleeding disorders. If there is a suspicion of a different bleeding disorder, additional tests may be necessary.
Test Name | HEMOPHILIA A CARRIER DETECTION Test |
---|---|
Components | *Factor VIII*vWF Antigen*Factor VIII / vWF Ratio |
Price | 2450.0 AED |
Sample Condition | 3 mL whole blood in 1 Blue Top (Sodium Citrate) tube. Mix thoroughly by inversion. Transport to Lab within 4 hours. If this is not possible, make PPP within 1 hour of collection as follows: Centrifuge sample at 3600 rpm for 15 min. & transfer supernatant to a clean plastic tube. Centrifuge this supernatant again at 3600 rpm for 15 mins. & finally transfer the supernatant (PPP) to 1 labelled, clean plastic screw capped vial. FREEZE IMMEDIATELY. Ship frozen. DO NOT THAW. Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15)is mandatory. |
Report Delivery | Sample 1st & 3rd Mon by 11 am; Report Next day |
Method | Electromechanical Clot Detection, EIA |
Test type | Disorders of Coagulation |
Doctor | Hematologist |
Test Department: | |
Pre Test Information | Overnight fasting is preferred. Duly filled Coagulation Requisition Form (Form 15)is mandatory. It is recommended that patient discontinues Heparin for 1 day and Oral Anticoagulants for 7 days prior to sampling as these drugs may affect test results. Discontinuation should be with prior consent of treating Physician. |
Test Details | Hemophilia A carrier detection test is a genetic test used to determine if an individual carries the gene mutation for hemophilia A. Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII. Carriers of the gene mutation do not typically show symptoms of the disorder but can pass the gene mutation onto their children. The test is usually performed on women who have a family history of hemophilia A or who are at risk of being carriers. It involves analyzing a blood sample to detect the presence of the gene mutation responsible for hemophilia A. The test can provide important information for family planning and genetic counseling. If a woman is found to be a carrier, there is a 50% chance that she will pass the gene mutation onto her children. This information can help individuals make informed decisions about their reproductive options and medical management. It is important to note that this test specifically detects the gene mutation for hemophilia A and not other types of hemophilia or bleeding disorders. If there is a suspicion of a different bleeding disorder, additional tests may be necessary. |